Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

APYX holding history

Apyx Medical Corp in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APYX overviewAll 13F holders of APYXFull Q2 2026 holdings

Shares (Q2 2026)
12,751
Value
$57.3K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of APYX by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,751$57.3K<0.1%−218,594−94.5%ReducedHolders
Q1 2026231,345$853.7K<0.1%+229,915+16,078.0%AddedHolders
Q4 20251,430$5.00K<0.1%−11,286−88.8%ReducedHolders
Q3 202512,716$27.2K<0.1%+12,311+3,039.8%AddedHolders
Q2 2025405$911<0.1%−3,903−90.6%ReducedHolders
Q1 20254,308$5.90K<0.1%+457+11.9%AddedHolders
Q4 20243,851$6.08K<0.1%+3,146+446.2%AddedHolders
Q3 2024705$874<0.1%−568−44.6%ReducedHolders
Q2 20241,273$1.71K<0.1%+769+152.6%AddedHolders
Q1 2024504$685<0.1%−3,776−88.2%ReducedHolders
Q4 20234,280$11.2K<0.1%+3,880+970.0%AddedHolders
Q3 2023400$1.28K<0.1%00.0%UnchangedHolders
Q2 2023400$2.01K<0.1%−182−31.3%ReducedHolders
Q1 2023582$1.68K<0.1%−35−5.7%ReducedHolders
Q4 2022617$1.44K<0.1%−888,427−99.9%ReducedHolders
Q3 2022889,044$3.99M<0.1%+7,432+0.8%AddedHolders
Q2 2022881,612$5.17M<0.1%+881,612NewHolders
Q1 20220$00.0%−3,000−100.0%Sold outHolders
Q4 20213,000$38.0K<0.1%00.0%UnchangedHolders
Q3 20213,000$42.0K<0.1%00.0%UnchangedHolders
Q2 20213,000$31.0K<0.1%00.0%UnchangedHolders
Q1 20213,000$29.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.